metabolic dysfunction
Showing 1 - 25 of >10,000
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH) Trial
Enrolling by invitation
- Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
- Metabolic Associated-dysfunction Steatohepatitis (MASH)
- Standard of care acceptance-based behavioral weight loss program
- Occupational therapy dietary and lifestyle modifications
-
Wyoming, MichiganGastroenterology Associates of Western Michigan, PLC
Nov 2, 2023
Schizophrenia, Healthy Trial (Intranasal insulin, Placebo)
Not yet recruiting
- Schizophrenia
- Healthy
- Intranasal insulin
- Placebo
- (no location specified)
Feb 28, 2023
Polycystic Ovary Syndrome, Weight Gain, HbA1c Trial in Karachi (Empagliflozin 10 MG, MetFORMIN 500 Mg Oral Tablet)
Recruiting
- Polycystic Ovary Syndrome
- +2 more
- Empagliflozin 10 MG
- MetFORMIN 500 Mg Oral Tablet
-
Karachi, Sindh, PakistanSINA Yousuf Sb Goth
Nov 28, 2023
Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
Recruiting
- Asthma
-
San Francisco, CaliforniaUCSF Airway Clinical Research Center
Feb 23, 2023
Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)
Not yet recruiting
- Fatty Liver, Nonalcoholic
- SGLT2 inhibitor
- (no location specified)
Oct 31, 2023
NMR-based Metabolic Profiling Identifies High Risk of MAFLD
Not yet recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
- Metabolic Disease
- NMR-based metabolic profiling
-
Wuhan, Hubei, ChinaTongji hospital, Tongji Medical College, Huazhong University of
Feb 8, 2023
Asthma, Obesity Trial in Durham, Burlington (Mitoquinol, Placebo oral tablet)
Recruiting
- Asthma
- Obesity
- Mitoquinol
- Placebo oral tablet
-
Durham, North Carolina
- +1 more
Jan 26, 2023
Schizophrenia, Metabolic Disturbance, Eating Behavior Trial (accelerated theta burst stimulation)
Recruiting
- Schizophrenia
- +3 more
- accelerated theta burst stimulation
- Sham stimulation
-
Changsha, Hunan, ChinaSecond Xiangya Hospital Central South University
Nov 17, 2022
hsCAR and MAFLD: A Cross-sectional Study
Recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
- +2 more
- high-sensitivity C-reactive protein to albumin ratio
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Aug 2, 2023
Diabetes Type 2 Trial in Sherbrooke (Bariatric surgery, Nicotinic Acid)
Not yet recruiting
- Diabetes Mellitus Type 2
- Bariatric surgery
- Nicotinic Acid
-
Sherbrooke, Quebec, Canadacentre de recherche du CHUS
Jun 27, 2023
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Recruiting
- Fatty Liver Disease
- Fibrotouch
-
Beijing, Bejing, ChinaBejing Tsinghua Chang Gung Hospital
Jun 13, 2022
Fatty Liver Trial in Naples
Completed
- Fatty Liver
-
Naples, ItalyUniversity of Campania Luigi Vanvitelli
Mar 27, 2023
Fatty Liver Disease Trial in Cheras (Intermittent Fasting)
Recruiting
- Fatty Liver Disease
- Intermittent Fasting
-
Cheras, Kuala Lumpur, MalaysiaHospital Canselor Tuanku Muhriz
May 19, 2023
Metabolic Dysfunction-Associated Fatty Liver Disease, Obesity, Adolescent, Arterial Stiffness Trial in León (L-citrulline,
Enrolling by invitation
- Metabolic Dysfunction-Associated Fatty Liver Disease
- +2 more
- L-citrulline
- +2 more
-
León, Guanajuato, MexicoUniversidad de Guanajuato
Mar 24, 2023
Metabolic Dysfunction-associated Fatty Liver Disease, Cirrhosis Trial (Pioglitazone metformin tablets, Other drugs, Drug-free)
Not yet recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
- Cirrhosis
- Pioglitazone metformin tablets
- +2 more
- (no location specified)
Nov 15, 2023
Fatty Liver, NAFLD Trial (Coenzyme Q10 Forte® capsules)
Not yet recruiting
- Fatty Liver
- NAFLD
- Coenzyme Q10 Forte® capsules
- (no location specified)
Aug 8, 2023
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
Metabolic Associated Fatty Liver Disease in Chinese Population
Completed
- Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 13, 2022
Psoriasis, Metabolic Syndrome, Erectile Dysfunction Trial in Giza (lifestyle modification (exercise and control of diet))
Recruiting
- Psoriasis
- +2 more
- lifestyle modification (exercise and control of diet)
-
Giza, EgyptCairo Unoversity
Nov 20, 2022
Metabolic Syndrome, Coronary Microvascular Dysfunction Trial in Baltimore (Vericiguat, Placebo)
Not yet recruiting
- Metabolic Syndrome
- Coronary Microvascular Dysfunction
- Vericiguat
- Placebo
-
Baltimore, MarylandJohns Hopkins Hospital
Jan 25, 2023
Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
Active, not recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
-
Hangzhou, Zhejiang, ChinaThe First Clinical Medical College of Zhejiang Chinese Medical U
Sep 25, 2023
Polycystic Ovary Syndrome Trial in Birmingham (oral androgen challenge with dehydroepiandrosterone (DHEA))
Recruiting
- Polycystic Ovary Syndrome
- oral androgen challenge with dehydroepiandrosterone (DHEA)
-
Birmingham, West Midlands, United KingdomInstitute of Metabolism and Systems Research
Feb 8, 2022
Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) Trial in Hialeah Gardens
Recruiting
- Nonalcoholic Steatohepatitis (NASH)
- Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Miricorilant
- Placebo
-
Hialeah Gardens, FloridaSite #430
Nov 1, 2023
Mild Cognitive Impairment, Alzheimer, Hyperglycemia Trial (Coenzyme Q10, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- +3 more
- Coenzyme Q10
- Placebo
- (no location specified)
Sep 10, 2023